Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4400-4406

  Douce, Gill ^a   Giannelli, Valentina ^b   Pizza, Mariagrazia ^b   Lewis, David ^c   Everest, Paul ^a,d   Rappuoli, Rino ^b   Dougan, Gordon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHIRON VACCINES   (Italy)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL TOXIN; BACTERIAL VACCINE; CYTOKINE; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 5;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIUM MUTANT; CELL PROLIFERATION; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPLEEN CELL; TRAVELLER DIARRHEA;

EID: 0032794696     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4400-4406.1999     Document Type: Article

References (22)

1. Clements, J. D., N. M. Hartzog, and F. L. Lyon. 1988. Adjuvant activity of Escherichia coli heat labile enterotoxin and effect of induction of oral tolerance in mice to unrelated antigens. Vaccine 6:269-277.
2. de Haan, L., I. K. Feil, W. R. Verweij, M. Holtrop, W. G. Hol, E. Agsteribbe, and J. Wilschut. 1998. Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin. Eur. J. Immunol. 28:1243-1250.
3. Dickinson, B. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1617-1623.
4. Di Tommaso, A., G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G. Douce, and M.-T. De Magistris. 1996. Induction of antigen-specific anti-bodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:974-979.
5. Douce, G., M. Fontana, M. Pizza, R. Rappuoli, and G. Dougan. 1997. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect. Immun. 65:2821-2818.
6. Douce, G., M. M. Giuliani, V. Giannelli, M. G. Pizza, R Rappuoli, and G. Dougan. 1998. Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli. Vaccine 16:1065-1073.
7. Douce, G., M. Pizza, M. Roberts, R. Rappuoli, and G. Dougan. 1997. Mutant pertussis and Escherichia coli heat labile toxins as adjuvants for enhancing local and systemic immune responses to coadministered, nonliving antigens, p. 253-263. In M. M. Levine, G. C. Woodrow, J. Kaper, and G. S. Cobon (ed.), New generation vaccines, 2nd ed. Marcel Dekker, New York, N.Y.
8. Douce, G., C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domenghini, R. Rappuoli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA 92:1644-1648.
9. Galen, J. E., O. G. Gomez-Duarte, G. A. Losonsky, J. L Halpern, C. S. Lauderbaugh, S. Kaintuck, M. K. Reymann, and M. M. Levine. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum anti-body responses to expressed foreign antigens. Vaccine 15:700-708.
10. Giannelli, V., M. R. Fontana, M. M. Giuliani, D. Guangcai, R. Rappuoli, and M. Pizza. 1997. Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop. Infect. Immun. 65:331-334.
11. Giuliani, M. M., G. Del Giudice, V. Giannelli, G. Dougan, G. Douce, R Rappuoli, and M. Pizza. 1998. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J. Exp. Med. 187:1123-1132.
12. Jackson, R. J., K. Fujihashi, J. Xu-Amano, H. Kiyono, C. O. ElsoN, and J. R McGhee. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272-4279.
13. Levine, M. M., J. B. Kaper, R. E. Black, and M. L. Clements. 1983. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:510-550.
14. Lycke, N., and J. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59:301-308.
15. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholerae and Escherichia coli enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:2277-2281.
16. Magagnoli, C., R. Manetti, M. R Fontana, V. Giannelli, M. M. Giuliani, R Rappuoli, and M. Pizza. 1996. Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat-labile enterotoxin. Infect. Immun. 64:5435-5438.
17. Marchetti, M., M. Rossi, V. Giannelli, M. M. Giuliani, M. Pizza, S. Censini, A. Covacci, P. Massari, C. Pagliaccia, R. Manetti, J. L. Telford, G. Douce, G. Dougan, R. Rappuoli, and P. Ghiara. 1998. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16:33-37.
18. Pizza, M., M. R. Fontana, M. M. Giuliani, M. Domenighini, C. Magagnoii, V. Giannelli, D. Nucci, W. Hol, R. Manetti, and R. Rappuoli. 1994. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med. 180: 2147-2153.
19. VanCott, J. L., T. Kobayashi, M. Yamamoto, S. Pillai, J. R. McGhee, and H. Kiyono. 1996. Induction of pneumococcal polysaccharide-specific mucosal immune response by oral immunisation. Vaccine 14:392-398.
20. Verweij, W. R., L. de Haan, M. Holtrop, E. Agsteribbe, R. Brands, G. J. Van Scharrenburg, and J. Wilschut. 1998. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA response in mice by intranasal immunisation with influenza virus surface antigen. Vaccine 16:2069-2076.
21. Wiedermann, U., B. Jahn-Schmid, R. Fritsch, L. Bauer, H. Renz, D. Kraft, and C. Ebner. 1998. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen antigen. Clin. Exp. Immunol. 111:144-151.
22. Yamamoto, S., H. Kiyono, Y. Yamamoto, K. Imaoka, K. Fnjihashi, F. W. Van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267-5272.